According to the data from phase 3 clinical trials of the drug in 250 patients across 10 sites, the "drug works best in ...

The Drugs Controller General of India DCGI on Wednesday suspended the product PresVu produced by Entod Pharmaceuticals after ...

Regulatory approval to Entod Pharma for PresVu, meant to treat presbyopia, was revoked as the firm marketed it as a ...

Pilocarpine is already used to reduce pressure inside the eye in ophthalmic diseases like glaucoma, so ophthalmologists are already familiar with the drug, and that could assist take-up of Vuity.

The Central Drugs Standard Control Organisation (CDSCO) said that it was suspending its approval for the pilocarpine ...

The Drugs Controller General of India (DCGI) has suspended the approval granted to Mumbai-based Entod Pharmaceuticals for ...

This would enable someone with presbyopia to see better. Pilocarpine, itself, is not a new application in ophthalmology, or even, presbyopia. It has been used to treat glaucoma, though its use waned ...

Company response: One doctor evaluated the drug product compared to the reading glasses. DCGI response: “You are informed that the Pilocarpine Hydrochloride Ophthalmic Solution USP 1.25 per cent w/ is ...

India's drug regulator has suspended the permission granted to manufacture and sell their new eye drops, PresVu, which ...

In response to the various alleged misleading claims made by Entod Pharma in respect to its Opthalmologic product, Drugs ...